Rolipram, salbutamol and prostaglandin E2 suppress TNFα release from human monocytes by activating Type II cAMP-dependent protein kinase
- 31 August 2005
- journal article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 18 (4) , 277-284
- https://doi.org/10.1016/j.pupt.2004.12.012
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Differential Effects of Substrate on Type I and Type II PKA Holoenzyme DissociationBiochemistry, 2004
- Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 ReceptorJournal of Biological Chemistry, 2002
- Physiological Substrates of cAMP-Dependent Protein KinaseChemical Reviews, 2001
- The genetic subtypes of cAMP-dependent protein kinase — Functionally different or redundant?Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Molecular Cloning of a Tissue-Specific Protein Kinase (Cγ) from Human Testis—Representing a Third Isoform for the Catalytic Subunit of cAMP-Dependent Protein KinaseMolecular Endocrinology, 1990
- Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.Journal of Biological Chemistry, 1986
- Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase.Proceedings of the National Academy of Sciences, 1986
- Amino acid sequence of the regulatory subunit of bovine type II cAMP-dependent protein kinaseBiochemistry, 1984
- Amino acid sequence of the regulatory subunit of bovine type I cAMP-dependent protein kinaseBiochemistry, 1984
- Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3′; 5′-cyclic monophosphateBiochemical and Biophysical Research Communications, 1978